SEARCH

SEARCH BY CITATION

References

  • 1
    Baldi F, Ferrarini F, Longanesi A, Ragazzini M, Barbara L. Acid gastroesophageal reflux and symptom occurrence. Analysis of some factors influencing their association. Dig Dis Sci 1989; 34: 18903.
  • 2
    Levy S. Antacids/Laxatives: Catering to a Loyal Customer Base. Drug Topics. Available at: http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=123688, accessed on 9 December 2005.
  • 3
    Hamilton MI, Sercombe J, Pounder RE. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo. Dig Dis Sci 2002; 47: 547.
  • 4
    Hamilton MI, Sercombe J, Pounder RE. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine. Aliment Pharmacol Ther 2001; 15: 157983.
  • 5
    Robinson M, Rodriguez-Stanley S, Ciociola AA, et al. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole. Dig Dis Sci 2002; 47: 26573.
  • 6
    Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 1998; 115: 13359.
  • 7
    Xue S, Katz PO, Banerjee P, Tutuian R, Castell DO. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther 2001; 15: 13516.
  • 8
    Ours TM, Fackler WK, Richter JE, Vaezi MF. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol 2003; 98: 54550.
    Direct Link:
  • 9
    Orr WC, Harnish MJ. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity. Aliment Pharmacol Ther 2003; 17: 15538.
  • 10
    Fackler WK, Ours TM, Vaezi MF, Richter JE. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 2002; 122: 62532.
  • 11
    Wilder-Smith C, Merki H. Tolerance during dosing with H2 receptor antagonists. Scand J Gastroenterol 1992; 27 (Suppl. 193): 149.
  • 12
    Wilder-Smith C, Ernst T, Gennini M, Zeyen B, Halter F, Merki HS. Tolerance to oral H2 receptor antagonists. Dig Dis Sci 1990; 8: 97683.
  • 13
    Chey WD, Inadomi JM, Booher AM, Sharma VK, Fendrick AM, Howden CW. Primary-care physicians’ perceptions and practices on the management of GERD: results of a national survey. Am J Gastroenterol 2005; 100: 123742.
    Direct Link:
  • 14
    Khoury RM, Katz PO, Castell DO. Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers. Aliment Pharmacol Ther 1999; 13: 12114.
  • 15
    Tutuian R, Katz PO, Ahmed F, Korn S, Castell DO. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors. Aliment Pharmacol Ther 2002; 16: 4737.
  • 16
    Smout AJ, Jonkman JH, Peeters PA, De Bruin H. Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers. Aliment Pharmacol Ther 1995; 9: 516.
  • 17
    Nwokolo CU, Prewett EJ, Sawyer AM, Hudson M, Lim S, Pounder RE. Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study. Gastroenterology 1991; 101: 94853.